Combination Chemotherapy in Treating Children With Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2004-04-29
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 221
- Registration Number
- NCT00002590
- Locations
- 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
- Conditions
- Leukemia
- Interventions
- First Posted Date
- 2004-04-27
- Last Posted Date
- 2014-07-28
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 36
- Registration Number
- NCT00003783
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States
🇺🇸Sutter Cancer Center, Sacramento, California, United States
Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
- Conditions
- Unspecified Childhood Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2004-04-26
- Last Posted Date
- 2014-02-21
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 13
- Registration Number
- NCT00006463
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸University of California San Diego Cancer Center, La Jolla, California, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
- Conditions
- Childhood Germ Cell TumorExtragonadal Germ Cell TumorLeukemiaLymphomaNeuroblastomaOvarian CancerLiver CancerPsychosocial Effects of Cancer and Its TreatmentSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
- Interventions
- Procedure: psychosocial assessment and care
- First Posted Date
- 2004-04-26
- Last Posted Date
- 2014-02-14
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 359
- Registration Number
- NCT00002485
- Locations
- 🇺🇸
University of California Davis Medical Center, Sacramento, California, United States
🇺🇸Shands Hospital and Clinics, University of Florida, Gainesville, Florida, United States
🇺🇸Sylvester Cancer Center, University of Miami, Miami, Florida, United States
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 11
- Registration Number
- NCT00003735
- Locations
- 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Conditions
- LeukemiaMyelodysplastic Syndromes
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2014-08-06
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 496
- Registration Number
- NCT00003790
- Locations
- 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
- Conditions
- Lymphoma
- Interventions
- Biological: bleomycin sulfateBiological: filgrastimDrug: ABVD regimenRadiation: radiation therapy
- First Posted Date
- 2004-04-15
- Last Posted Date
- 2014-02-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 99
- Registration Number
- NCT00004010
- Locations
- 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
🇺🇸Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
- Conditions
- LymphomaKidney CancerLeukemiaNeuroblastomaSarcomaOral Complications
- Interventions
- Drug: Traumeel SOther: Placebo
- First Posted Date
- 2004-04-08
- Last Posted Date
- 2016-01-07
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 195
- Registration Number
- NCT00080873
- Locations
- 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
🇺🇸Children's Hospital of Orange County, Orange, California, United States
Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
- Conditions
- Intraocular Retinoblastoma
- Interventions
- Procedure: CryosurgeryProcedure: Infrared Laser TherapyRadiation: Iodine I-125Radiation: Radiation TherapyRadiation: Ruthenium Ru-106
- First Posted Date
- 2004-03-10
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 28
- Registration Number
- NCT00079417
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
- Conditions
- Central Nervous System TumorBrain Tumor
- Interventions
- Biological: filgrastimProcedure: autologous bone marrow transplantationProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2004-03-09
- Last Posted Date
- 2015-05-07
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 1
- Registration Number
- NCT00078988
- Locations
- 🇺🇸
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Children's Hospital and Research Center - Oakland, Oakland, California, United States
🇺🇸University of California Davis Cancer Center, Sacramento, California, United States